These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 11782716

  • 1. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation].
    Florio T, Arena S, Thellung S, Iuliano R, Corsaro A, Massa A, Villa V, Pattarozzi A, Diana F, Fusco A, Schettini G.
    Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716
    [Abstract] [Full Text] [Related]

  • 2. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T, Arena S, Thellung S, Iuliano R, Corsaro A, Massa A, Pattarozzi A, Bajetto A, Trapasso F, Fusco A, Schettini G.
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [Abstract] [Full Text] [Related]

  • 3. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
    Massa A, Barbieri F, Aiello C, Iuliano R, Arena S, Pattarozzi A, Corsaro A, Villa V, Fusco A, Zona G, Spaziante R, Schettini G, Florio T.
    Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806
    [Abstract] [Full Text] [Related]

  • 4. Oncogene transformation of PC Cl3 clonal thyroid cell line induces an autonomous pattern of proliferation that correlates with a loss of basal and stimulated phosphotyrosine phosphatase activity.
    Florio T, Scorziello A, Thellung S, Salzano S, Berlingieri MT, Fusco A, Schettini G.
    Endocrinology; 1997 Sep; 138(9):3756-63. PubMed ID: 9275062
    [Abstract] [Full Text] [Related]

  • 5. The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation.
    Massa A, Barbieri F, Aiello C, Arena S, Pattarozzi A, Pirani P, Corsaro A, Iuliano R, Fusco A, Zona G, Spaziante R, Florio T, Schettini G.
    J Biol Chem; 2004 Jul 09; 279(28):29004-12. PubMed ID: 15123617
    [Abstract] [Full Text] [Related]

  • 6. Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.
    Martelli ML, Trapasso F, Bruni P, Berlingieri MT, Battaglia C, Vento MT, Belletti B, Iuliano R, Santoro M, Viglietto G, Fusco A.
    Exp Cell Res; 1998 Nov 25; 245(1):195-202. PubMed ID: 9828116
    [Abstract] [Full Text] [Related]

  • 7. Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.
    Florio T.
    Mol Cell Endocrinol; 2008 May 14; 286(1-2):40-8. PubMed ID: 17913342
    [Abstract] [Full Text] [Related]

  • 8. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
    Iuliano R, Trapasso F, Le Pera I, Schepis F, Samà I, Clodomiro A, Dumon KR, Santoro M, Chiariotti L, Viglietto G, Fusco A.
    Cancer Res; 2003 Feb 15; 63(4):882-6. PubMed ID: 12591742
    [Abstract] [Full Text] [Related]

  • 9. The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.
    Pera IL, Iuliano R, Florio T, Susini C, Trapasso F, Santoro M, Chiariotti L, Schettini G, Viglietto G, Fusco A.
    Oncogene; 2005 Apr 28; 24(19):3187-95. PubMed ID: 15735685
    [Abstract] [Full Text] [Related]

  • 10. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
    Arena S, Pattarozzi A, Massa A, Esteve JP, Iuliano R, Fusco A, Susini C, Florio T.
    Mol Endocrinol; 2007 Jan 28; 21(1):229-46. PubMed ID: 17021051
    [Abstract] [Full Text] [Related]

  • 11. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).
    Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P, Baldassarre G, Santoro M, Viglietto G, Fusco A.
    Mol Cell Biol; 2000 Dec 28; 20(24):9236-46. PubMed ID: 11094075
    [Abstract] [Full Text] [Related]

  • 12. Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene.
    Florio T, Scorizello A, Fattore M, D'Alto V, Salzano S, Rossi G, Berlingieri MT, Fusco A, Schettini G.
    J Biol Chem; 1996 Mar 15; 271(11):6129-36. PubMed ID: 8626400
    [Abstract] [Full Text] [Related]

  • 13. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L, Jiyu L, Gongwei, Yingbin L, Yiyu Q, Zhiwei Q.
    Hepatogastroenterology; 2009 Mar 15; 56(94-95):1253-60. PubMed ID: 19950772
    [Abstract] [Full Text] [Related]

  • 14. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
    Notas G, Kolios G, Mastrodimou N, Kampa M, Vasilaki A, Xidakis C, Castanas E, Thermos K, Kouroumalis E.
    J Hepatol; 2004 May 15; 40(5):792-8. PubMed ID: 15094227
    [Abstract] [Full Text] [Related]

  • 15. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo.
    Trapasso F, Yendamuri S, Dumon KR, Iuliano R, Cesari R, Feig B, Seto R, Infante L, Ishii H, Vecchione A, During MJ, Croce CM, Fusco A.
    Carcinogenesis; 2004 Nov 15; 25(11):2107-14. PubMed ID: 15231692
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.
    de Bruin C, Feelders RA, Waaijers AM, van Koetsveld PM, Sprij-Mooij DM, Lamberts SW, Hofland LJ.
    J Mol Endocrinol; 2009 Jan 15; 42(1):47-56. PubMed ID: 18852217
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin modulates PI3K-Akt, eNOS and NHE activity in the ciliary epithelium.
    Ghosh S, Choritz L, Geibel J, Coca-Prados M.
    Mol Cell Endocrinol; 2006 Jul 11; 253(1-2):63-75. PubMed ID: 16764985
    [Abstract] [Full Text] [Related]

  • 18. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J, Waser B, Schaer JC, Cescato R, Brazeau JF, Rivier J, Reubi JC.
    J Med Chem; 2003 Dec 18; 46(26):5597-605. PubMed ID: 14667214
    [Abstract] [Full Text] [Related]

  • 19. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
    Paling NR, Welham MJ.
    Biochem J; 2002 Dec 15; 368(Pt 3):885-94. PubMed ID: 12220225
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.
    Barbieri F, Pattarozzi A, Gatti M, Porcile C, Bajetto A, Ferrari A, Culler MD, Florio T.
    Endocrinology; 2008 Sep 15; 149(9):4736-46. PubMed ID: 18566118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.